Upcoming generation nanoengineered antimicrobial delivery system for targeting multidrug-resistant microbes

Area of Science:

• Nanomedicine and Drug Delivery
• Antimicrobial Resistance Research
• Biotechnology and Bioengineering

Background:

• Increasing infections necessitate advanced antimicrobial strategies.
• Conventional antimicrobials exhibit limitations including poor bioavailability, toxicity, and antimicrobial resistance.
• Antimicrobial resistance poses a significant global health threat, demanding novel therapeutic approaches.

Purpose of the Study:

• To review the rationale and advantages of nanoengineering-based smart delivery systems for resistance-proof antimicrobial agents (RPAA).
• To explore the potential mechanisms of action and delivery for these advanced systems.
• To highlight the challenges and opportunities in developing RPAA nano-drug delivery therapeutics.

Main Methods:

• Review of current literature on nanoengineering, drug delivery systems, and antimicrobial resistance.
• Analysis of the properties and potential mechanisms of nanoengineered RPAA.
• Discussion of challenges and future directions in the development of RPAA delivery systems.

Main Results:

• Nanoengineering offers a promising approach to develop resistance-proof antimicrobial agents (RPAA).
• Smart delivery systems enhance properties like bioavailability, biocompatibility, and targeted pathogen binding.
• These systems have the potential to overcome multidrug resistance and reduce drug toxicity.

Conclusions:

• Nanoengineered RPAA with smart delivery systems represent a next-generation therapeutic strategy.
• Development of these systems is crucial for combating the global challenge of drug resistance.
• Further research is needed to address challenges and fully realize the potential of these advanced drug delivery tools.